Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs VYM✓SelectedUSD · VYMGSK vs VYM performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs VYM

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+6.9%
VYM return
+15.4%
Excess return
-8.5%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioVYMExcessAlpha
1D-1.6%-1.7%+0.1%-0.1%
7D-4.7%-4.9%+0.1%-0.5%
30D-4.7%-2.5%-2.2%-2.8%
3M-8.8%-4.5%-4.3%-5.1%
6M-4.6%+2.0%-6.6%-6.9%
YTD+1.0%+11.4%-10.4%-8.8%
1Y+6.9%+15.2%-8.3%-6.5%
All+6.9%+15.4%-8.5%-6.5%

Cumulative growth

Daily Returns

Daily percentage return beside VYM.

Daily Out/Under-Performance

Portfolio return minus VYM return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VYM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded VYM wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling